ZEZied Ibn Elhadj

Zied Ibn Elhadj

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Zied Ibn Elhadj has a total of 231 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Design of the Middle East African Registry for Women’s Cardiovascular Diseases: Protocol for a Multicenter Observational Study

    by Salma Charfeddine, Leila Abid, Sarra Chenik, Aiman Ghrab, Oussama Haddar, Iheb Ben Krayen, Selim Boudiche, Haithem Touati, Oumaima Ayedi, Mohamed Amine Ammar, et al.

    Background: Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in the Middle East and Africa (MEA), with a rising incidence particularly among women. Regional factors such as limited health care access, cultural barriers, and sex-specific risk factors exacerbate this burden. Despite this, women remain significantly underrepresented in cardiovascular research, and no large-scale, multicenter prospective trials have been conducted to provide national data. To address this gap, we established the Middle East African Registry Women Cardiovascular Disease (MEA-WCVD) to create a comprehensive database on the epidemiological profile and management of heart failure (HF), atrial fibrillation (AF), ischemic heart disease (IHD), and valvular heart disease (VHD) in women. Objective: The primary aim of this study is to compare the management of CVDs in women and men across MEA countries in accordance with current clinical practice guidelines. The study also seeks to identify gender-based disparities in health care insurance, income, and access to cardiovascular services. Methods: The MEA-WCVD is a prospective, multicenter, observational study enrolling consecutive patients aged ≥18 years with diagnosed HF, AF, IHD, or VHD across 25 tertiary care centers. Participants provide informed consent during a single visit, and trained investigators collect sociodemographic, clinical, and treatment data via electronic case report forms. The electronic case report form captures general characteristics (age, gender, and comorbidities) and diagnosis-specific details (imaging, guideline-based therapies, and complications). Data are stored in a centralized, contract research organization–managed database (Eshmoun-Clinical Research, Tunisia). An initial 75-day enrollment phase (May 2023-July 2023) is followed by a planned 1-year follow-up for outcome analysis. Data will be analyzed using SPSS (version 25) to compare gender disparities in management and outcomes using multivariable regression and survival analyses. Results: The MEA-WCVD study was funded in April 2023, and data collection began in May 2023. As of July 2023, a total of 15,366 participants have been enrolled across 25 centers. A 1-year follow-up is expected to be completed by July 2024. Data analysis is planned to commence in July 2024, with primary results anticipated for publication in March 2025. The study aims to establish the largest registry in the MEA region for HF, AF, IHD, and VHD, providing valuable insights into demographic trends, clinical management, and adherence to current guidelines. Conclusions: The MEA-WCVD registry will provide essential real-world data on the management and outcomes of the most prevalent CVDs (HF, AF, IHD, and VHD) in the MEA region. By directly comparing standard care management between men and women, this study will highlight gender disparities and inform future strategies for equitable cardiovascular care. The registry is expected to contribute to the largest contemporary cohort of patients with CVD in the region, advancing knowledge in cardiovascular epidemiology and clinical practice.

  • Open Access

    Design and Rationale of the National Tunisian Registry of Percutaneous coronary Intervention: Protocol for a Prospective, Multicenter Observational study (Preprint)

    by Rania Hammami, Slim Boudiche, Rami Tlili, Nejeh Ben Hlima, Ahmed Jamel, Bassem Rekik, Rym Gribaa, Imtinen Ben Mrad, Selma Charfeddine, Tarek Ellouz, et al.

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Coronary diseases remain the first cause of death in the world; the management of this condition has improved, thanks to new technical tools and multicentric registries. Recently in Tunisia, the number of intervention procedures has markedly increased, giving the explosion of cardiovascular risk factors among Tunisian people. Objective: The aim of the study was to investigate the in-hospital and one-year clinical outcome of patients treated with percutaneous coronary intervention (PCI) in Tunisia. Methods: We will conduct a prospective, multicentric, observational study including patients > 18 year-old who underwent a PCI between 31January and 30 June 2020. The primary end point are the occurrence of a major adverse cardiovascular event , defined as cardiovascular death, myocardial infarction, cerebrovascular accident, and target vessel revascularization with either repeat PCI or coronary artery bypass surgery (CABG). Secondary end-points consist in procedural success rate, stent thrombosis, and the rate of redo-PCI/CABG for in-stent restenosis. Results: Results will be available at the end of the study as well as the demographic profile and general risk profile of Tunisian patients undergoing PCI. The complexity level of procedures, as left main, bifurcation, chronic occlusion PCI will be analyzed and immediate as well as long term results will be determined. NATURE-PCI will be the first national multicentric registry of angioplasty in Africa. Conclusions: This study would add data and provide a valuable opportunity for real-world clinical epidemiology and practice in the field of interventional cardiology in Tunisia with insights into the uptake of contemporary coronary artery disease in this developing region. Clinical Trial: clinicaltrials.gov

  • The IMPACTOR-CTO Trial

    by Anton A. Obedinskiy, Evgeny I. Kretov, Marouane Boukhris, Vladislav P. Kurbatov, Alexander G. Osiev, Zied Ibn Elhadj, Nataliya R. Obedinskaya, Sami Kasbaoui, Igor O. Grazhdankin, Alexey A. Prokhorikhin, et al.


  • Percutaneous Coronary Intervention of Chronic Total Occlusions in Patients With Low Left Ventricular Ejection Fraction

    by Alfredo R. Galassi, Marouane Boukhris, Aurel Toma, Zied Ibn Elhadj, Lobna Laroussi, Oliver Gaemperli, Michael Behnes, Ibrahim Akin, Thomas F. Lüscher, Franz J. Neumann, et al.


  • Vitamine C + sérum bicarbonaté versus sérum bicarbonaté seul dans la prévention de la néphropathie induite par les produits de contraste

    by L. Laroussi, M. Triki, Z. Ibn Elhaj, A. Ben Halima, M. Boukhris, W. Ben Amara, H. Keskes, S. Kraiem, D. Lahidheb, S. Marrakchi, et al.


  • Giant left main coronary artery aneurysm revealed by a myocardial infarction

    by Zied Ibn Elhadj, Marouane Boukhris, Lobna Laaroussi, Afef Ben Halima, Salem Kachboura

  • Open Access

    Which diuretic for which hypertensive patient?

    by Marouane Boukhris, Farouk Abcha, Zied Ibn Elhadj, Salem Kachboura


  • Predictive scores in chronic total occlusions percutaneous recanalization: only fashionable or really useful?

    by Marouane Boukhris, Kambis Mashayekhi, Zied Ibn Elhadj, Alfredo R. Galassi

    Predictive scores in chronic total occlusions percutaneous recanalization: only fashionable or really useful?


    • 27 October 2015
      • Vol. 10  (4) , 208-214
    Open Access

    The GuideLiner Catheter: A Useful Tool in the Armamentarium of the Interventional Cardiologist

    by Marouane Boukhris, Salvatore Azzarelli, Salvatore Davide Tomasello, Zied Ibn Elhadj, Francesco Marzà, Alfredo R. Galassi

    Regardless of the clinical setting, a good back-up represents one of the most important conditions to ensure guide wire and balloon advancement and stent delivery. As a “mother and child” system, the GuideLiner catheter (Vascular Solutions Inc., Minneapolis, MN, USA) provides an extension to the guide catheter with better coaxial alignment and stability. We report two didactic cases showing the usefulness of the GuideLiner device in everyday catheterization laboratory practice. The first case was a primary percutaneous coronary intervention (PCI) in a 71-year-old diabetic man admitted for inferior ST-elevation myocardial infarction, related to tight proximal stenosis in a dominant tortuous and calcified left circumflex. The second case was an elective PCI in a 76-year-old man admitted for stable angina (Canadian Cardiovascular Society [CCS] class III), related to focal intra-stent restenosis of a saphenous venous graft to the left anterior descending. In both cases, the GuideLiner catheter provided a good back-up insuring the success of PCI and drug-eluting stents implantation, with a good in-hospital outcome.